Several antibodies have been detected in association with DM, most notably anti-Mi2+ (5–20% of patients), anti-TIF1y+ (15–25%), anti-MDA5+ (7–15%) and anti-NXP2+ (15–25%) [20,28]. This evidence concerns the gene IFIH1 and dermatomyositis.